Electrode array for monitoring of physiological parameters and devices including or utilizing same, the electrode array including an active electrode configured to provide an electrical signal and at least two inactive electrodes configured to collect the electrical signal transferred from the active electrode, wherein each of the at least two inactive electrodes are positioned at a different predetermined distance from the active electrode.

A system for controlling blood pressure includes a wearable interface having an internal contact surface, the wearable interface configured to at least partially encircle a first portion of a first limb of a subject, a sensing module carried by the wearable interface and configured to determine at least a change in blood pressure of the first limb of the subject, and an energy application module carried by the wearable interface and configured to apply energy of two or more types to the first limb of the subject.

A system for monitoring includes: multiple EEG sensors spatially positioned on a layer of tissue for capturing EEG signals of a patient; multiple amplifiers coupled with the EEG sensors for amplifying the captured signals; and a low frequency oscillator for generating a synchronizing signal which is distributed to the amplifiers for synchronizing the digitization of the captured signals; wherein each amplifier includes: a voltage controlled oscillator for an adjustable frequency reference; an analog to digital converter for converting the amplified signal to a digital value; and a microcontroller for controlling the frequency of the voltage controlled oscillator and operation of the analog to digital converter by using the synchronizing signal.

A system for monitoring includes: multiple EEG sensors spatially positioned on a layer of tissue for capturing EEG signals of a patient; multiple amplifiers coupled with the EEG sensors for amplifying the captured signals; and a low frequency oscillator for generating a synchronizing signal which is distributed to the amplifiers for synchronizing the digitization of the captured signals; wherein each amplifier includes: a voltage controlled oscillator for an adjustable frequency reference; an analog to digital converter for converting the amplified signal to a digital value; and a microcontroller for controlling the frequency of the voltage controlled oscillator and operation of the analog to digital converter by using the synchronizing signal.

An in-ear device including a cloth, which defines a concave surface, at least one electrode in or on the cloth, and a conductive track connected to the at least one electrode. Also, a method of monitoring neurological or physiological diseases or disorders with the in-ear device and a method of collecting electroencephalography data with the in-ear device. Further, a process for manufacturing the in-ear device.

An in-ear device including a cloth, which defines a concave surface, at least one electrode in or on the cloth, and a conductive track connected to the at least one electrode. Also, a method of monitoring neurological or physiological diseases or disorders with the in-ear device and a method of collecting electroencephalography data with the in-ear device. Further, a process for manufacturing the in-ear device.

A method for processing physiological signals (S.sub.EMG; S.sub.EEG) acquired from a subject (S) allows the detection of an imminent loss of balance of the subject and the generation of a signal (Aout) indicating the imminent loss of balance. The method comprises: the reception of a plurality of electromyographic signals (S.sub.EMG) representative of a detected muscle activity of a plurality of selected muscles of the subject, as well as a plurality of brain signals (S.sub.EEG) acquired by means of an electroencephalogram and representative of a cortical activity of the subject during said muscle activity; the analysis and processing of the electromyographic signals (S.sub.EMG) in order to extract a muscle activity pattern, MAP, and generate an indicator of normality/abnormality of the detected muscle activity pattern; the analysis and processing of the brain signals (S.sub.EEG) in order to generate one or more cortical response indicators of the subject upon occurrence of said detected muscle activity (I.sub.EGg; LF(k)); and a classification step, wherein at least one indicator (MA(k)) of normality/abnormality of the MAP and one or more of said cortical response indicators are correlated to generate a signal (Aout) indicating an imminent loss of balance.

A method for processing physiological signals (S.sub.EMG; S.sub.EEG) acquired from a subject (S) allows the detection of an imminent loss of balance of the subject and the generation of a signal (Aout) indicating the imminent loss of balance. The method comprises: the reception of a plurality of electromyographic signals (S.sub.EMG) representative of a detected muscle activity of a plurality of selected muscles of the subject, as well as a plurality of brain signals (S.sub.EEG) acquired by means of an electroencephalogram and representative of a cortical activity of the subject during said muscle activity; the analysis and processing of the electromyographic signals (S.sub.EMG) in order to extract a muscle activity pattern, MAP, and generate an indicator of normality/abnormality of the detected muscle activity pattern; the analysis and processing of the brain signals (S.sub.EEG) in order to generate one or more cortical response indicators of the subject upon occurrence of said detected muscle activity (I.sub.EGg; LF(k)); and a classification step, wherein at least one indicator (MA(k)) of normality/abnormality of the MAP and one or more of said cortical response indicators are correlated to generate a signal (Aout) indicating an imminent loss of balance.

The present invention provides methods and systems for enhancing clinical safety of psychoactive therapies (e.g., 5-HT2A agonists (e.g., LSD and psilocybin), dissociatives, and empathogens) when administered in a clinical treatment setting. In particular, the invention provides methods and systems for monitoring a patient and an attendant, e.g., via an access module capable of relaying session data and/or deriving a patient response metric.

The present technology relates to a control device and a control method capable of providing a more convenient electroencephalogram input user interface.

Provided is a control device including a detection unit configured to perform detection of a brain wave included in a measured biometric signal of a user and detection of a user action based on information other than the brain wave included in the biometric signal, and a processing unit configured to perform a predetermined process based on the brain wave in a case where the user action is a predetermined action. For example, the present technology can be applied to a measurement device capable of measuring a brain wave signal.